Abstract:Vascular calcification is a common complication in atherosclerosis. Bone morphogenetic protein -2 (BMP-2) plays an important role in atherosclerotic vascular calcification. The aim of this study was to determine the effect of oxidized low-density lipoprotein (oxLDL) on BMP-2 protein expression in human coronary artery endothelial cells (CAECs), the roles of Toll-like receptor (TLR) 2 and TLR4 in oxLDLinduced BMP-2 expression and the signaling pathways involved. Human CAECs were stimulated with oxLDL. The roles of TLR2 and TLR4 in oxLDL-induced BMP-2 expression were determined by pretreatment with neutralizing antibody, siRNA and overexpression. Stimulation with oxLDL increased cellular BMP-2 protein levels in a dosedependent manner (40-160 μg/ml). Pretreatment with neutralizing antibodies against TLR2 and TLR4 or silencing these two receptors reduced oxLDL-induced BMP-2 expression. Over-expression of TLR2 and TLR4 enhanced the cellular BMP-2 response to oxLDL. Furthermore, oxLDL was colocalized with TLR2 and TLR4. BMP-2 expression was associated with activation of nuclear factor-κB (NF-κB), p38 mitogenactivated protein kinase (MAPK) and extracellular signal-related kinase (ERK) 1/2. Inhibition of NF-κB and ERK1/2 reduced BMP-2 expression while inhibition of p38 MAPK had no effect. In conclusion, oxLDL induces BMP-2 expression through TLR2 and TLR4 in human CAECs. The NF-κB and ERK1/2 pathways are involved in the signaling mechanism. These findings underscore an important role for TLR2 and TLR4 in mediating the BMP-2 response to oxLDL in human CAECs and indicate that these two immunoreceptors contribute to the mechanisms underlying atherosclerotic vascular calcification. Calcification in intima is often associated with atherosclerosis. Atherosclerotic calcification of coronary artery is a significant risk for the unsuccessful coronary intervention and ballooninduced coronary artery dissection (1), and calcification is found to be an indicator of plaque instability (2). While inhibition of atherosclerotic calcification might be a promising approach to stabilize atherosclerotic plaques, the molecular mechanism(s) underlying atherosclerotic cascular calcification remains incompletely understood. It is known that oxLDL accumulation in the vascular wall provokes the development of atherosclerosis and vascular calcification (3). BMP-2 is an osteogenic factor. It is expressed in calcified human atherosclerotic plaque. Cells from the atherogenic aortic wall express BMP-2 in vitro and formed calcified nodules with prolonged culture (4). BMP-2 mRNA level increased after oxLDL stimulation in human CAECs (5). However it remains unclear whether oxLDL up-regulates BMP-2 protein levels in CAECs. Further, the signaling mechanism that regulates cellular BMP-2 response to oxLDL is unknown. Accumulating evidence indicates that atherosclerosis is an inflammatory process involving a network of vascular cells, monocytes, T lymphocytes. Pro-inflammatory mediators, including cytokines, chemokines and growth factors, play critical roles in the inflammatory process associated with atherosclerosis. Native LDL and electronegative LDL increase the expression and release of interleukine (IL)-8, http://www.jbc.org/cgi/doi/10.1074/jbc.M110.214619 The latest version is at JBC Papers in Press. Published on February 16, 2011 as Manuscript M110.214619

Abstract 19603: Bone Morphogenetic Protein 6 and Oxidized Low-density Lipoprotein Synergistically Recruit Osteogenic Differentiation in Endothelial Cells

Bone Morphogenetic Protein 6 and Oxidized Low-Density Lipoprotein Synergistically Recruit Osteogenic Differentiation in Endothelial Cells

Oxidized Low Density Lipoprotein Induces Bone Morphogenetic Protein-2 in Coronary Artery Endothelial Cells via Toll-like Receptors 2 and 4

Oxidized low-density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via toll-like receptors

Oxidized low-density lipoprotein and β-glycerophosphate synergistically induce endothelial progenitor cell ossification

GW24-e2290 Effects of Oxidatively Modified Low Density Lipoprotein on Proliferation and Osteodifferentiation of Mesenchymal Stem Cells That Co-Cultured with Vascular Smooth Muscle Cells

Advanced Oxidation Protein Products Induce Vascular Calcification by Promoting Osteoblastic Trans-Differentiation of Smooth Muscle Cells Via Oxidative Stress and ERK Pathway

Both Atorvastatin and Probucol Can Down-regulate BMP-2 Expression Induced by Oxidized Low Density Lipoprotein in Human Umbilical Vein Cells

Atorvastatin Downregulates BMP-2 Expression Induced by Oxidized Low-Density Lipoprotein in Human Umbilical Vein Endothelial Cells

Inflammation induces endothelial‐to‐mesenchymal transition and promotes vascular calcification through downregulation of BMPR2

Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification

Oxidized Low-Density Lipoprotein Alters Endothelial Progenitor Cell Populations.

Abstract 130: Ox-LDL Impairs the Survival of Bone Marrow Stem Cells Partially Through Membrane Damage Independent of ROS Production in Vitro

Uptake of ox-LDL by binding to LRP6 mediates oxidative stress-induced BMSCs senescence promoting obesity-related bone loss

Abstract 272: Chronic Hyperlipidemia Alters the Population of Endothelial Progenitor Cells in Bone Marrow and Peripheral Circulation Via Both ROS-dependent and Independent Mechanisms

IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways

oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway

Effects of oxidized low density lipoprotein on transformation of valvular myofibroblasts to osteoblast-like phenotype

[Effect of oxidative low-density lipoprotein on the proliferation of bone marrow stem cell- derived smooth muscle cells]

Endothelial Cell and Macrophage Regulation of Vascular Smooth Muscle Cell Calcification Modulated by Cholestane-3 Beta, 5 Alpha, 6 Beta-Triol

CCAAT/Enhancer-Binding Protein Alpha Is a Novel Regulator of Vascular Smooth Muscle Cell Osteochondrogenic Transition and Vascular Calcification